A3P Product Lifecycle

Control strategy / CPV / AQbD / Statistical intervals / ICHQ12

A3P Product Lifecycle

When?

19 & 20 Mars 2025

Format?

Conférences, ateliers, visites de sites & exposition

Introduction

The A3P  Analytical, CPV, ICHQ12, Statistics and QbD GIC are working together on these days dedicated to the product life cycle. These 5 themes are all working towards the same goal: Product life cycle Management.  
QbD is a real product and process design tool, based on science and risk analysis, which will enable us to build a process control strategy culminating in Process Validation.
The CPV, a monitoring process, will confirm the validated state of the process over time.
ICH Q12 provides a framework for the management of post-approval changes affecting the quality of pharmaceutical products. Its main aim is to facilitate the management of these changes, make the process more predictable and efficient, and minimize regulatory variations.
Statistical and analytical tools are used throughout the product life cycle.
This coherence between these 5 themes has led A3P to bring them together during the “Product Lifecycle - 2025” days. Members of these GIC will be presenting conferences based on their work, control strategy, CPV implementation and the platform approach. The application of statistical tools, such as experimental design, and predictive tools for development will also be presented.
An exhibition of supplier companies will enable you to discover the market innovations available to manufacturers, and the implementation of these approaches deployed during the product life cycle at partner workshops. 2 visits to analysis laboratories will also be offered.

Programme

RELATED ARTICLES

What does 21 CFR Part 11 mean in everyday online analytics?

La Vague 83 / October 2024
The article highlights some details how FDA 21 CFR Part 11 and EU Annex 11 shall be implemented and can be “lived” effectively. By reaching compliance more easily, operational efficiency...

EU GMP Annex 1. Implementation of the Contamination Control Strategy

La Vague 80 / Janvier 2024
For several years, and especially since the covid pandemic, the pharmaceutical industry essentially in bioprocesses has been witnessing a significant shift towards single-use technology...

The challenge of digitalizing production records

La Vague 83 / Octobre 2024
Within the pharmaceutical industry, there has been a significant surge in articles and publications related to digitalization, with abundant references to concepts such as Pharma 4.0....